Weight-Loss Pill Approval Likely to Prompt Overhaul of Packaged Food and Fast-Food Products

Packaged food companies and fast-food chains may soon face significant shifts in consumer behavior as appetite-suppressing GLP-1 weight-loss pills are poised to reshape the market. With Novo Nordisk’s Wegovy GLP-1 pill recently approved by the U.S. Food and Drug Administration and set to launch in January, analysts predict a wave of changes in how food is marketed, labeled, and consumed.

The pills, considered a more accessible alternative to injectable versions of the medication, are expected to gain rapid adoption due to their lower cost and ease of use. "We are seeing people cut (back) specifically on salty snacks, liquor, soda, drinks, and bakery snacks, and more focused on protein and fiber", said JP Frossard, consumer foods analyst at Rabobank. "So we expect food companies and also restaurants to cater to this audience that is growing."

Food Industry Adjustments Already Underway

With the increasing popularity of GLP-1 injections, food and beverage companies have already begun adapting to shifts in consumer preferences. Conagra Brands, for example, has started labeling its Healthy Choice frozen meals as "GLP-1 friendly", emphasizing high protein and fiber content. According to a company spokesperson, these meals are selling faster than competing products with similar claims. In May, Conagra plans to introduce additional recipes under the same labeling and collaborate with major grocers like Walmart and Kroger to market these products effectively.

Similarly, French dairy company Danone has reported double-digit growth in its high-protein Oikos Greek yogurt line, with trends accelerating alongside the adoption of GLP-1 medications. Nestle, the world’s largest food company, has introduced frozen meals branded specifically for GLP-1 users under a line called Vital Pursuit.

This trend has also reached the restaurant industry. Chipotle recently launched a "High Protein Menu" that includes single servings of chicken or steak, while Olive Garden and other chains have added smaller, more affordable portion options to their menus. Stephen Kennedy, marketing head at Noodles & Company, said these additions are intended to give customers "options that satisfy without going overboard."

sbb-itb-e2779c3

Weight-Loss Pills Expected to Broaden Reach

The introduction of GLP-1 pills is anticipated to expand the user base of these medications significantly. Some 12% of American adults currently use GLP-1 drugs, according to a poll released by health policy organization KFF. However, the convenience and affordability of the pills could drive a broader adoption, particularly among people who may have been hesitant about injectable versions.

Andrew Rocco, stock strategist at Zacks Investment Research, called Novo Nordisk’s approval "groundbreaking" and noted that the pill delivers the same weight-loss results as the injection. He emphasized that the food industry needs to focus on "high protein, smaller portions, and functional food innovation" to align with the evolving market.

Data supports the potential for long-term changes. A Cornell Research study using purchase data from approximately 150,000 households found that families using GLP-1 medications reduced spending at grocery stores by 5.3% and at fast-food restaurants by about 8% on average. Sylvia Hristakeva, one of the study’s co-authors, highlighted the pill’s potential to extend these changes. "The decreases we saw will likely show up in a much broader slice of the population because of weight-loss pills", she said, adding that the lower price and user-friendly format increase the likelihood of prolonged usage.

While the study observed only modest increases in spending in categories such as yogurt and fresh fruit, these shifts have been enough to capture the attention of major food producers and restaurants, who are pivoting to meet the demands of the growing GLP-1 user base.

As the weight-loss pill prepares to hit the market, the food industry may find itself at a critical crossroads, requiring innovation and agility to keep up with changing consumer habits. The next year promises to reveal just how significantly these pills will alter the landscape of packaged food and dining.

Read the source